Aug 23, 2023 / 12:00AM GMT
Sarah Qiu -
Good day, everyone. Thank you for standing by. Please be advised that today's call is being recorded. This is Sarah Qiu, Associate Director of Investor Relations. Welcome to Brii Bio's First Half of 2023 Earnings Call. Our interim results announcement can be found on the Investor Relations section of our company website.
Before we start, I would like to remind everyone that today's call may contain forward-looking statements, which involve several risks and uncertainties. Actual results and outcomes may differ materially from those mentioned in today's announcements and this discussion. In addition, any forward-looking statements represent our views only as of the date of this call and should not be relied upon as representing our views as of any subsequent date. We specifically disclaim any obligation to update such statements.
Joining us today on the call from Brii Bio's executive management team are Dr. Zhi Hong, Chairman and Chief Executive Officer; Dr. David Margolis, Chief Medical Officer; Dr. Susannah Cantrell, Chief Business Officer; and Dr. Ankang Li, Chief Strategy and
Half Year 2023 Brii Biosciences Ltd Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot